Endothelial mediators of 17β-estradiol-induced coronary vasodilation in the isolated rat heart

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 4, 2004, Pages 569-575

  Santos, R L ^a   Abreu, G R ^a   Bissoli, N S ^a   Moyses M R ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

Coronary arteries; Endothelium derived relaxing factors; Estrogen; Vasodilation

Indexed keywords

CLOTRIMAZOLE; CYTOCHROME P450 INHIBITOR; DEOXYCHOLATE SODIUM; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ESTRADIOL; INDOMETACIN; MUSCLE RELAXANT AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DRUG MECHANISM; DRUG RESPONSE; ENDOTHELIUM CELL; ESTROGEN THERAPY; FEMALE; HEART MUSCLE RELAXATION; HEART MUSCLE TENSION; HORMONE SUBSTITUTION; ISCHEMIC HEART DISEASE; ISOLATED HEART; MALE; NONHUMAN; POSTMENOPAUSE; RAT; RISK REDUCTION; SEX DIFFERENCE;

ANIMALIA;

EID: 2442543404     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000400014     Document Type: Article

References (33)

1. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE & Hennekens CH (1991). Postmenopausal estrogen therapy and cardiovascular disease. New England Journal of Medicine, 325: 756-762.
2. Barret-Connor E & Bush TL (1991). Estrogen and coronary heart disease in women. Journal of the American Medical Association, 256: 1861-1867.
3. Grady D, Rubin SM, Petiti DB, Fox CS, Black D, Ettinger B, Ernster YL & Cumings SR (1992). Hormone therapy to prevent disease and prolong life in postmenopausal women. Annals of Internal Medicine, 117: 1016-1037.
4. Mendelsohn ME & Karas RH (1994). Estrogen and the blood vessel wall. Current Opinion in Cardiology, 9: 619-626.
5. Farhat MY, Lavigne MC & Ramwell PW (1996). The vascular protective effects of estrogen. FASEB Journal, 10: 615-624.
6. Hayashi T, Fukuto JM, Ignarro LJ & Chaudhuri G (1992). Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proceedings of the National Academy of Sciences, USA, 89: 11259-11263.
7. Gisclard V, Miller VM & Vanhoutte PM (1988). Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. Journal of Pharmacology and Experimental Therapeutics, 244: 19-22.
8. Mendelsohn ME (2000). Nongenomic, estrogen receptor-mediated activation of endothelial nitric oxide synthase. How does it work? What does it mean? Circulation Research, 87: 677-682.
9. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H & Iguchi A (1995). Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochemical and Biophysical Research Communications, 214: 847-855.
10. Hishikawa K, Nakani T, Marumo T, Suzuki H, Kato R & Saruta T (1995). Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Letters, 360: 291-293.
11. Haliwell B & Grootveld M (1987). The measurement of free radical reactions in humans. Some thoughts for future experimentations. FEBS Letters, 213: 9-16.
12. Kauser K & Rubanyi GM (1997). Potential cellular signalling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen. Journal of Vascular Research, 34: 229-236.
13. Jun SS, Chen Z, Pace MC & Shaul PW (1998). Estrogen upregulates cyclo-oxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. Journal of Clinical Investigation, 102: 176-183.
14. Golding EM & Kepler TE (2001). Role of estrogen in modulating EDHF-mediated dilations in the female rat middle cerebral artery. American Journal of Physiology, 280: H2417-H2423.
15. Wu Y, Huang A, Sun D, Falck JR, Koller A & Kaley G (2001). Gender specific compensation for the lack of nitric oxide in the mediation of flow-induced arteriolar dilation. American Journal of Physiology, 280: H2456-H2461.
16. Collins P, Rosano GMC, Jiang C, Lindsay D, Sarrel PM & Poole-Wilson PA (1993). Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet, 341: 1264-1265.
17. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA & Collins P (1991). Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. British Journal of Pharmacology, 104: 1033-1037.
18. Stevenson JC (2000). Cardiovascular effects of oestrogens. Journal of Steroid Biochemistry and Molecular Biology, 74: 387-393.
19. Döring HJ (1990). The isolated perfused heart according to Langendorff technique - function - application. Physiologia Bohemoslovaca, 39: 482-496.
20. Moysés MR, Barker LA & Cabral AM (2001). Sex hormone modulation of serotonin-induced coronary vasodilation in isolated heart. Brazilian Journal of Medical and Biological Research, 34: 949-958.
21. Dzau VJ (1988). Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation, 77 (Suppl I): 4-13.
22. Oelskers WHK (1996). Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids, 61: 166-171.
23. Mendelsohn ME & Karas RH (1999). Mechanisms of disease: the protective effects of estrogen on the cardiovascular system. New England Journal of Medicine, 340: 1801-1811.
24. Valverde MA, Rojas P, Amigo J, Cosmelli D, Patricio O, Bahamonde MI, Mann GE, Vergara C & Latorre R (1999). Acute activation of maxi-K channels (hSIo) by estradiol binding to the β subunit. Science, 285: 1929-1931.
25. 2+ currents in aortic smooth muscle cells. European Journal of Pharmacology, 294: 625-635.
26. Johnson BD, Zheng W, Korach KS, Sheuer T, Catterall WA & Rubanyi GM (1997). Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. Journal of General Physiology, 110: 135-140.
27. 2+ channels in smooth muscle cells. FASEB Journal, 12: 613-619.
28. G-nitro-L-argininein rats. American Journal of Physiology, 263: H1090-H1094.
29. Cohen RA, Plane F, Najibi S, Huk I, Malinski T & Garland CJ (1997). Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proceedings of the National Academy Sciences, USA, 94: 4193-4198.
30. Garland CJ, Plane F, Kemp BK & Cocks TM (1995). Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends in Pharmacological Sciences, 16: 23-30.
31. Shimokawa H, Yasutake H, Fujii K et al. (1996). The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. Journal of Cardiovascular Pharmacology, 28: 703-711.
32. Huang A, Wu Y, Sun D, Koller A & Kaley G (2001). Effect of estrogen on flow-induced dilation in NO deficiency: role of prostaglandins and EDHF. Journal of Applied Physiology, 9: 2561-2566.
33. Nagao T & Vanhoutte PM (1992). Hyperpolarization as a mechanism for endothelium-dependent relaxation in the porcine coronary artery. Journal of Physiology, 445: 335-367.